These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Evaluation of platelet deposition and neointimal hyperplasia of heparin-coated small-caliber ePTFE grafts in a canine femoral artery bypass model. Lin PH, Bush RL, Yao Q, Lumsden AB, Chen C. J Surg Res; 2004 May 01; 118(1):45-52. PubMed ID: 15093716 [Abstract] [Full Text] [Related]
3. Silyl-heparin bonding improves the patency and in vivo thromboresistance of carbon-coated polytetrafluoroethylene vascular grafts. Laredo J, Xue L, Husak VA, Ellinger J, Singh G, Zamora PO, Greisler HP. J Vasc Surg; 2004 May 01; 39(5):1059-65. PubMed ID: 15111862 [Abstract] [Full Text] [Related]
4. Quantitative evaluation of ibuprofen treatment on thrombogenicity of expanded polytetrafluoroethylene vascular grafts. Gloviczki P, Hollier LH, Dewanjee MK, Trastek VF, Kopesky KR, Kaye MP. Surgery; 1984 Feb 01; 95(2):160-8. PubMed ID: 6695334 [Abstract] [Full Text] [Related]
7. Naturally produced extracellular matrix is an excellent substrate for canine endothelial cell proliferation and resistance to shear stress on PTFE vascular grafts. Schneider A, Chandra M, Lazarovici G, Vlodavsky I, Merin G, Uretzky G, Borman JB, Schwalb H. Thromb Haemost; 1997 Nov 01; 78(5):1392-8. PubMed ID: 9408025 [Abstract] [Full Text] [Related]
8. Platelet adhesion in polytetrafluoroethylene (PTFE) vascular grafts in vivo and the influence of increased intramuscular pressure--an experimental model. Christenson JT, Qvarfordt P, Strand SE, Arvidsson D, Sjöberg T, Olsson PI. Thromb Haemost; 1983 Dec 30; 50(4):881-4. PubMed ID: 6420926 [Abstract] [Full Text] [Related]
9. Combined arachidonic acid and ADP platelet inhibition maximizes patency of small-diameter vascular grafts. Valentin LI, Sicard GA, Freeman MB, Allen BT, McGoff MA, Anderson CB. Surgery; 1988 Aug 30; 104(2):178-84. PubMed ID: 3135624 [Abstract] [Full Text] [Related]
10. Inhibition of platelet deposition on polytetrafluoroethylene grafts by antiplatelet agents. Kon ND, Hansen KJ, Martin MB, Meredith JW, Meredith JH, Cordell AR. Surgery; 1984 Nov 30; 96(5):870-3. PubMed ID: 6387989 [Abstract] [Full Text] [Related]
11. Prevention of platelet aggregation and adherence to prosthetic vascular grafts by aspirin and dipyridamole. Oblath RW, Buckley FO, Green RM, Schwartz SI, DeWeese JA. Surgery; 1978 Jul 30; 84(1):37-44. PubMed ID: 149385 [No Abstract] [Full Text] [Related]
12. Pseudointimal thrombogenicity changes in small arterial grafts. Seeger JM, Borgeson M, Lawson G. Surgery; 1990 Jun 30; 107(6):620-6. PubMed ID: 2141191 [Abstract] [Full Text] [Related]
13. Improved endothelialization and reduced thrombosis by coating a synthetic vascular graft with fibronectin and stem cell homing factor SDF-1α. De Visscher G, Mesure L, Meuris B, Ivanova A, Flameng W. Acta Biomater; 2012 Mar 30; 8(3):1330-8. PubMed ID: 21964214 [Abstract] [Full Text] [Related]
14. Enhanced intimal thickening of expanded polytetrafluoroethylene grafts coated with fibrin or fibrin-releasing vascular endothelial growth factor in the pig carotid artery interposition model. Walpoth BH, Zammaretti P, Cikirikcioglu M, Khabiri E, Djebaili MK, Pache JC, Tille JC, Aggoun Y, Morel D, Kalangos A, Hubbell JA, Zisch AH. J Thorac Cardiovasc Surg; 2007 May 30; 133(5):1163-70. PubMed ID: 17467424 [Abstract] [Full Text] [Related]